Pharmaceutical Medicines

Approx. Rs 15,000 / VialGet Latest Price

Product BrochureProduct Details:

Darzalex Injection is used in the treatment of multiple myeloma, which is a type of cancer of plasma cells.

Darzalex Injection is given as an IV infusion into veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Infusion reaction such as swollen face, lips, mouth, tongue or throat, difficulty swallowing or breathing are very common side effects. This medicine may reduce the number of blood cells (decrease white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells while taking this medicine.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. Use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Approx. Rs 4,000 / VialGet Latest Price

Product BrochureProduct Details:

Intacept 50mg Injection is a medicine used to treat a variety of conditions such as??ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease. It provides relief from swelling, pain, and redness associated with various disorders and improves physical function.04-Feb-2022

Approx. Rs 1,700 / PieceGet Latest Price

Product BrochureProduct Details:

Peg Grafeel Injection is a man-made form of human granulocyte colony-stimulating factor (G-CSF) analog. It stimulates the growth of white blood cells and helps in decreasing the chances of infection in patients who are undergoing chemotherapy procedures for cancer.

Approx. Rs 1,000 / BottleGet Latest Price

Product BrochureProduct Details:

Tenvir-EM Tablet is a combination medicine used for the treatment of treat human immunodeficiency virus (HIV) infections. This medicine is not a cure for HIV; it only prevents the virus from multiplying in your body.

Approx. Rs 1,200 / BottleGet Latest Price

Product BrochureProduct Details:

X Vir 0.5mg Tablet is used in the treatment of HIV infection and chronic hepatitis B virus (HBV) infection. It prevents the multiplication of virus in human cells. This stops the virus from producing new viruses and clears up your infection

Approx. Rs 1,000 / BottleGet Latest Price

Product BrochureProduct Details:

Molnupiravir is indicated for treatment of mild to moderate coronavirus disease (COVID-19) in adults with a positive SARS-COV-2 diagnostic test and whMolnupiravir is the oral prodrug of beta-D-N4-hydroxycytidine (NHC), a ribonucleoside that has shown antiviral activity against SARS-CoV-2 in vitro and in clinical trials.1,2 NHC uptake by viral RNA-dependent RNA-polymerases results in viral mutations and lethal mutagenesis.3,4 On December 23, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for molnupiravir for the treatment of adults with mild to moderate COVID-19 who are within 5 days of symptom onset, who are at high risk of progressing to severe disease, and for whom alternative antiviral therapies are not accessible or clinically appropriate.5,6
As a mutagenic ribonucleoside antiviral agent, there is a theoretical risk that molnupiravir will be metabolized by the human host cell and incorporated into the host DNA, leading to mutations. Molnupiravir has been evaluated in 2 in vivo rodent mutagenicity assays. One study produced equivocal results. In the other study, there was no evidence for mutagenicity.6 The FDA concluded that, based on the available genotoxicity data and the 5-day duration of treatment, molnupiravir has a low risk for genotoxicity.6In addition, there have been concerns about the potential effects of molnupiravir on SARS-CoV-2 mutation rates; the FDA has required that the manufacturer monitor genomic databases for the emergence of SARS-CoV-2 variants.o have at least one risk factor for developing severe illness1.